@article{5d85fde21c60479e8a9f138bd2862fda,
title = "A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach",
keywords = "Biosimilar Pharmaceuticals/administration & dosage, Blood Cell Count, Filgrastim/administration & dosage, Hematopoietic Stem Cell Mobilization, Heterocyclic Compounds/administration & dosage, Humans, Lymphoma, Non-Hodgkin/blood, Multiple Myeloma/blood, Propensity Score, Retrospective Studies",
author = "Francesco Lanza and Francesco Saraceni and Annalisa Pezzi and Massimo Martino and Alberto Bosi and Nicola Cascavilla and Pellegrino Musto and Eliana Zuffa and Monica Tani and Claudia Cellini and Daniele Laszlo and Francesca Bonifazi",
year = "2017",
month = sep,
doi = "10.1002/ajh.24817",
language = "English",
volume = "92",
pages = "E557--E559",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "9",
}